Abstract:Dynamic changes in synaptic strength rely on de novo protein synthesis and protein degradation by the ubiquitin proteasome system (UPS). Disruption of either of these cellular processes will result in significant impairments in synaptic plasticity and memory formation. Mutations in several genes encoding regulators of mRNA translation and members of the UPS have been associated with an increased risk for the development of autism spectrum disorders. It is possible that these mutations result in a similar imbalance in protein homeostasis (proteostasis) at the synapse. This review will summarize recent work investigating the role of the UPS in synaptic plasticity at glutamatergic synapses, and propose that dysfunctional proteostasis is a common consequence of several genetic mutations linked to autism spectrum disorders. Dynamic changes in synaptic strength rely on de novo protein synthesis and protein degradation by the ubiquitin proteasome system (UPS). Disruption of either of these cellular processes will result in significant impairments in synaptic plasticity and memory formation. Mutations in several genes encoding regulators of mRNA translation (i.e. FMR1) and protein degradation (i.e. UBE3A) have been associated with an increased risk for autism spectrum disorders and intellectual disability (ASD/ID). These mutations similarly disrupt protein homeostasis (proteostasis). Compensatory changes that reset the rate of proteostasis may contribute to the neurological symptoms of ASD/ID. This review summarizes recent work investigating the role of the UPS in synaptic plasticity at glutamatergic synapses, and proposes that dysfunctional proteostasis is a common consequence of several genetic mutations linked to ASD. This article is part of a mini review series: "Synaptic Function and Dysfunction in Brain Diseases".

The Ubiquitin–Proteasome System in Synapses

The Proteasome-Associated Deubiquitinating Enzyme Usp14 Is Essential For The Maintenance Of Synaptic Ubiquitin Levels And The Development Of Neuromuscular Junctions

Perturbed proteostasis in autism spectrum disorders

The Ubiquitin-Proteasome System and Memory: Moving Beyond Protein Degradation

The Ubiquitin-Proteasome System and Molecular Chaperone Deregulation in Alzheimer’s Disease

The Ubiquitin–Proteasome System in Immune Cells

Role of the ubiquitin–proteasome system in brain ischemia: Friend or foe?

ER stress and the unfolded protein response in neurodegeneration

Neurodevelopmental Disorders (NDD) Caused by Genomic Alterations of the Ubiquitin-Proteasome System (UPS): the Possible Contribution of Immune Dysregulation to Disease Pathogenesis

Recent pharmacological insights on abating toxic protein species burden in neurological disorders: Emphasis on 26S proteasome activation

Exploring the Role of Ubiquitin-Proteasome System in the Pathogenesis of Parkinson's Disease

Copper Homeostasis and the Ubiquitin Proteasome System

Synaptic Secretion and Beyond: Targeting Synapse and Neurotransmitters to Treat Neurodegenerative Diseases

Interlinked destinies: How ubiquitin-proteasome and autophagy systems underpin neurocognitive outcomes

Ubiquitination-Proteasome System (UPS) and Autophagy Two Main Protein Degradation Machineries in Response to Cell Stress

Deubiquitylating enzymes in neuronal health and disease

Proteasome-Associated Syndromes: Updates on Genetics, Clinical Manifestations, Pathogenesis, and Treatment

Deubiquitinases in muscle physiology and disorders

Reversible Phosphorylation of the 26S Proteasome

Exploring the Role of Ubiquitin–Proteasome System in Parkinson's Disease